{
    "organizations": [],
    "uuid": "a0b735f34815063d050a461eb029d64e11f18800",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cormedix-qtrly-loss-per-share-015/brief-cormedix-qtrly-loss-per-share-0-15-idUSFWN1R10WG",
    "ord_in_thread": 0,
    "title": "BRIEF-Cormedix Qtrly Loss Per Share ‍$0.15​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 19, 2018 / 9:03 PM / Updated 9 minutes ago BRIEF-Cormedix Qtrly Loss Per Share ‍$0.15​ Reuters Staff March 19 (Reuters) - Cormedix Inc: * CORMEDIX INC - QTRLY LOSS PER SHARE ‍$0.15​ * CORMEDIX INC - ‍AT DEC 31, 2017, CO HAD $12.0 MILLION IN CASH AND SHORT-TERM INVESTMENTS​ * CORMEDIX -‍EXPECTS CASH, SHORT-TERM INVESTMENTS AT DEC 31 PLUS PROCEEDS OF ATM PROGRAM, PROPOSED BACKSTOP FACILITY TO FUND REQUIREMENTS INTO Q3 2018​ Source text - bit.ly/2IEi2Ua Further company coverage:",
    "published": "2018-03-19T23:00:00.000+02:00",
    "crawled": "2018-03-19T23:17:47.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "qtrly",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "cormedix",
        "inc",
        "cormedix",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "cormedix",
        "inc",
        "dec",
        "co",
        "million",
        "cash",
        "cormedix",
        "cash",
        "investment",
        "dec",
        "plus",
        "proceeds",
        "atm",
        "program",
        "proposed",
        "backstop",
        "facility",
        "fund",
        "requirement",
        "q3",
        "source",
        "text",
        "company",
        "coverage"
    ]
}